奧普光電(002338.SZ):正籌劃收購長春長光宇航複合材料67.78%股權 明起停牌
格隆匯11月25日丨奧普光電(002338.SZ)公佈,公司正在籌劃發行股份及支付現金方式購買資產事項。公司擬向長春市飛翔復材投資中心(有限合夥)、長春市快翔復材投資中心(有限合夥)和自然人股東在內的交易對方通過發行股份及支付現金的方式收購長春長光宇航複合材料有限公司(“長光宇航”)67.78%股權,並視洽談情況收購長光宇航其他股東持有的股份。
此次交易根據初步測算,預計涉及的金額將達到重大資產重組的標準。根據深圳證券交易所的相關規定,經公司申請,公司股票自2021年11月26日開市時起開始停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.